Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "evidity.com"

29
Business Relations
30
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 29
From Domain Role To Domain Path Aktionen
/biotheranostics-announces-inclusion-of-breast-cancer-index-in-the-national-comprehensive-cancer-network-nccn-breast-cancer-guidelines-for-prediction-of-benefit-from-extended-endocrine-thera/
/biotheranostics-announces-inclusion-of-breast-cancer-index-in-the-national-comprehensive-cancer-network-nccn-breast-cancer-guidelines-for-prediction-of-benefit-from-extended-endocrine-thera/
/biotheranostics-announces-inclusion-of-breast-cancer-index-in-the-national-comprehensive-cancer-network-nccn-breast-cancer-guidelines-for-prediction-of-benefit-from-extended-endocrine-thera/
/biotheranostics-announces-inclusion-of-breast-cancer-index-in-the-national-comprehensive-cancer-network-nccn-breast-cancer-guidelines-for-prediction-of-benefit-from-extended-endocrine-thera/
/haemonetics-to-acquire-cardiva-medical-inc-to-expand-hospital-portfolio/
/akili-interactive-a-leader-in-digital-medicine-to-become-publicly-traded-through-combination-with-social-capital-suvretta-holdings-corp-i/
/akili-interactive-a-leader-in-digital-medicine-to-become-publicly-traded-through-combination-with-social-capital-suvretta-holdings-corp-i/
/akili-interactive-a-leader-in-digital-medicine-to-become-publicly-traded-through-combination-with-social-capital-suvretta-holdings-corp-i/
/akili-interactive-a-leader-in-digital-medicine-to-become-publicly-traded-through-combination-with-social-capital-suvretta-holdings-corp-i/
/akili-interactive-a-leader-in-digital-medicine-to-become-publicly-traded-through-combination-with-social-capital-suvretta-holdings-corp-i/
/acufocus-announces-fda-approval-for-the-ic-8-apthera-intraocular-lens-the-first-and-only-small-aperture-lens-for-cataract-surgery/
/acufocus-announces-fda-approval-for-the-ic-8-apthera-intraocular-lens-the-first-and-only-small-aperture-lens-for-cataract-surgery/
/acufocus-announces-fda-approval-for-the-ic-8-apthera-intraocular-lens-the-first-and-only-small-aperture-lens-for-cataract-surgery/
/acufocus-announces-fda-approval-for-the-ic-8-apthera-intraocular-lens-the-first-and-only-small-aperture-lens-for-cataract-surgery/
/acufocus-announces-fda-approval-for-the-ic-8-apthera-intraocular-lens-the-first-and-only-small-aperture-lens-for-cataract-surgery/
/magnolia-medical-technologies-wins-patent-infringement-lawsuit-against-kurin-inc/
/acufocus-announces-fda-approval-for-the-ic-8-apthera-intraocular-lens-the-first-and-only-small-aperture-lens-for-cataract-surgery/
/digital-medicine-leader-akili-to-list-on-nasdaq-following-successful-business-combination-with-social-capital-suvretta-holdings-corp-i/
/sonde-health-raises-19-25-million-series-b-to-build-the-next-generation-of-voice-based-health-monitoring/
/bd-magnolia-medical-technologies-announce-commercial-collaboration-to-help-reduce-blood-culture-contamination-and-improve-testing-accuracy/